Toggle Main Menu Toggle Search

Open Access padlockePrints

Physiology and pathophysiology of poly(ADP-ribosyl)ation

Lookup NU author(s): Professor Alexander Burkle

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

One of the immediate eukaryotic cellular responses to DNA breakage is the covalent post-translational modification of nuclear proteins with poly(ADP-ribose) from NAD+ as precursor, mostly catalysed by poly(ADP-ribose) polymerase-1 (PARP-1). Recently several other polypeptides have been shown to catalyse poly(ADP-ribose) formation. Poly(ADP-ribosyl)ation is involved in a variety of physiological and pathophysiological phenomena. Physiological functions include its participation in DNA-base excision repair, DNA-damage signalling, regulation of genomic stability, and regulation of transcription and proteasomal function, supporting the previously observed correlation of cellular poly(ADP-ribosyl)ation capacity with mammalian life. The pathophysiology effects are mediated through PARP-1 overactivity, which can cause cell suicide by NAD+ depletion. It is apparent that the latter effect underlies the pathogenesis of a wide range of disease states including type-1 diabetes, ischaemic infarcts in various organs, and septic or haemorrhagic shock. Therefore pharmacological modulation of poly(ADP-ribosyl)ation may prove to be an exciting option for various highly prevalent, disabling and even lethal diseases. BioEssays 2001. © 2001 John Wiley and Sons, Inc.


Publication metadata

Author(s): Burkle A

Publication type: Review

Publication status: Published

Journal: BioEssays

Year: 2001

Volume: 23

Issue: 9

Pages: 795-806

ISSN (print): 0265-9247

ISSN (electronic): 1521-1878

URL: http://dx.doi.org/10.1002/bies.1115

DOI: 10.1002/bies.1115

PubMed id: 11536292


Share